Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$538,472
+$16,679 QoQ
Shares Held
1,487
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#2,126
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Acropolis Investment Management, LLC holds $13,272,644 across 8 Drug Manufacturers - General names. AMGN ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
20,115 | $5,108,606 | |
| 2 | LLY |
ELI LILLY & Co
|
2,014 | $2,415,652 | |
| 3 | ABBV |
AbbVie Inc.
|
7,039 | $1,771,293 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,768 | $1,769,188 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
17,771 | $1,023,965 | |
| 6 | AMGN |
Amgen Inc
This page
|
1,487 | $538,472 | |
| 7 | PFE |
Pfizer Inc
|
18,379 | $442,566 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,606 | $202,902 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $538,472 | 1,487 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $521,793 | 1,483 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $482,454 | 1,474 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $350,210 | 1,241 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $297,637 | 1,066 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $341,770 | 1,097 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $265,331 | 1,018 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $327,687 | 1,017 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $317,761 | 1,017 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $284,035 | 999 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $287,731 | 999 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $259,353 | 965 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $213,583 | 962 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $236,189 | 977 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $257,649 | 981 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $217,736 | 966 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $238,920 | 982 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $233,598 | 966 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $239,818 | 1,066 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $223,495 | 1,051 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $261,056 | 1,071 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $266,475 | 1,071 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $247,623 | 1,077 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $251,872 | 991 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $233,737 | 991 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $197,661 | 975 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||